In 2023, hypnotic and sedative medicine sales in Canada stood at an estimated [value in 2023]. Based on forecasted data, the sales are expected to slightly decline over the next five years from 2024 to 2028. The value per capita is projected to decrease from 3.8 USD in 2024 to 3.6 USD in 2028, indicating a stable yet gradually contracting market. Year-on-year variations show a subtle annual decline, while the compound annual growth rate (CAGR) over the forecasted period also reflects a minor regression.

Steady demand reduction for hypnotic and sedative medicines.
Potential impact of regulatory changes and health awareness campaigns.
Possible advancements in alternative therapies affecting the pharmaceutical market share.